GenAns Biotechnology Co., Ltd.
PrivateLast Round
Series A
Jul 30, 2026
Total Funding Raised
$14.3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
GenAns Biotechnology Co., Ltd. is a biotechnology company that develops gene therapy and biopharmaceutical therapeutics for central nervous system and ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenAns Biotechnology Co., Ltd. Comparables
Compare GenAns Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zhongmou Therapeutics | 79% | |
| Capsida Biotherapeutics | 78% | |
| Latus Bio | 78% |
GenAns Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 30, 2026 |
GenAns Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CITIC Capital | Series A |
| Beijing Pharmaceutical and Health Industry Investment Fund | Early Funding, Series A |
| Huatai Zijin Investment | Early Funding, Series A |
| Gaorong Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Raised Series A with CITIC Capital and Huatai Zijin Investment.
GenAns Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenAns Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is GenAns Biotechnology Co., Ltd. a public or private company?
GenAns Biotechnology Co., Ltd. is a private company.
What is the current stock price of GenAns Biotechnology Co., Ltd.?
GenAns Biotechnology Co., Ltd. is a private company with no public stock price. Caplight tracks GenAns Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is GenAns Biotechnology Co., Ltd. worth (valuation)?
Valuation information for GenAns Biotechnology Co., Ltd. is not publicly available.
Can I buy GenAns Biotechnology Co., Ltd. stock?
GenAns Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenAns Biotechnology Co., Ltd.'s last funding round?
GenAns Biotechnology Co., Ltd.'s most recent funding round was Series A on July 30, 2026.
Who are the main investors in GenAns Biotechnology Co., Ltd.?
Key investors in GenAns Biotechnology Co., Ltd. include CITIC Capital, Beijing Pharmaceutical and Health Industry Investment Fund, Huatai Zijin Investment, Gaorong Capital.
Will GenAns Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for GenAns Biotechnology Co., Ltd..
How can I track GenAns Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenAns Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.